BSE filing, NSE: GKB. Summary written from the filing by ALFA Finder's alert engine.
GKB Ophthalmics Ltd: key numbers
- Share price
- ₹60.10
- Market cap
- ₹30.29 Cr
- Revenue (annual)
- ₹149.1 Cr
- Net profit (annual)
- ₹1.22 Cr
- P/E (TTM)
- 9.3×Sector 52.0×
- Promoter holding
- 51.15%+0.00% QoQ
- FII holding
- 1.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GKB Ophthalmics Ltd
All →GKB Ophthalmics Annual General Meeting
GKB Ophthalmics filed minutes of its 44th AGM held on 25 August 2026. It approved financial statements and re-appointed directors, declaring no dividend due to operating losses.
GKB Ophthalmics Annual General Meeting
GKB Ophthalmics Ltd held its 44th Annual General Meeting on August 25, 2026. Key resolutions included financial statement adoption and re-appointment of senior directors.
GKB Ophthalmics Q1 FY27 Results: Turns Profitable, Net Profit ₹1.8 Cr
GKB Ophthalmics Ltd reported revenue from operations of ₹33 Cr (+2.2% YoY) and net profit of ₹1.8 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.8 Cr
GKB Ophthalmics Other Announcement
GKB Ophthalmics has provided shareholders with a web-link to access the Annual Report for F.Y. 2025-26, fulfilling Regulation 36(1)(b) disclosure requirements.
GKB Ophthalmics Annual General Meeting
GKB Ophthalmics Ltd has announced its 44th Annual General Meeting for August 25, 2026. Consequently, the Register of Members will be closed from August 19 to August 25.
GKB Ophthalmics Annual Report
GKB Ophthalmics Ltd. submitted its 44th Annual Report and AGM notice for the financial year 2025-26. The meeting is scheduled for August 25, 2026, at its registered office.
Other board meeting date announcements
All →Augmont Enterprises Board Meeting Date
Augmont Enterprises scheduled a Board meeting for November 4, 2026, to approve unaudited Q1 and H1 financial results. Trading window remains closed until 48 hours post-declaration.
Linc Board Meeting Date
Linc Ltd announced that its Board of Directors meeting is scheduled for 5 November 2026. The agenda includes approval of unaudited financial results for Q1 and H1 FY27.
NDR Auto Components Board Meeting Date
NDR Auto Components intimated its board meeting for November 4, 2026, to approve Q1 and H1 FY27 results. No financial figures are reported.
Reliance Chemotex Industries Board Meeting Date
Reliance Chemotex notified a Board Meeting on 05 Nov 2026 to approve unaudited results for Q1 FY27. No financial figures or decisions are yet reported.
Andhra Sugars Board Meeting Date
The Andhra Sugars Limited intimated a board meeting on 07 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes 09 Nov 2026.
Inventure Growth & Securities Board Meeting Date
Inventure Growth & Securities Limited intimated a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated quarterly financial results for September 2026. Trading window closes 06 Nov 2026.